Discovery Laboratories’ Proprietary Aerosol Drug Delivery Technology Showcased at the International Society for Aerosols in Medicine Annual Meeting

WARRINGTON, Pa., June 22, 2011 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced that scientific data relating to the Company's proprietary aerosolization technology platform was presented at the 2011 International Society for Aerosols in Medicine (ISAM) Annual Meeting. The annual ISAM congress brings together experts in the biotechnology and medical technology industries along with academic thought leaders dedicated to all aspects of aerosol research in medicine.
MORE ON THIS TOPIC